How I Made $5000 in the Stock Market

These Stocks Moved the Most Today: Nvidia, Exact Sciences, Walmart, AMD, Alphabet, Palo Alto Networks, and More

Nov 20, 2025 05:38:00 -0500 by Mackenzie Tatananni | #Technology

Traders working at the New York Stock Exchange. (NYSE)

Key Points

Stocks fell Thursday, as the market locked in its biggest blown gain since April after Nvidia’s earlier rally fizzled.

These stocks made notable moves:

Nvidia stock fell 3.2% after rising sharply earlier in the session on the back of a better-than-expected third-quarter earnings report. The chip maker also issued rock-solid revenue guidance: For the current fourth quarter, it’s expecting revenue in a range with a midpoint of $65 billion, well above the $62.2 billion analysts were expecting. Nvidia CEO Jensen Huang said the AI business was looking robust, and sales for the company’s Blackwell chip were “off the charts.”

Nvidia’s decline dragged other AI plays lower. Chip maker Micron Technology, software developer Palantir Technologies, and server maker Super Micro Computer fell 11%, 5.9%, and 6.4%, respectively.

Advanced Micro Devices was down 7.9%. It, too, had traded higher earlier in the day. The Commerce Department approved the sale of up to 70,000 advanced AI chips to two companies based in the Middle East, according to The Wall Street Journal. AMD has an agreement worth billions of dollars to work with one of the companies, Saudi Arabia’s Humain.

Exact Sciences surged 17% after Abbott Laboratories agreed to purchase the cancer screening company in a cash deal worth around $21 billion. Exact Sciences stockholders will receive $105 a share in the acquisition. Abbott also will absorb Exact Sciences’ estimated $1.8 billion of net debt, for a total enterprise value of around $23 billion. Abbott shares fell 1.7%.

Walmart gained 6.5%. The world’s largest retailer posted adjusted earnings of 62 cents a share and $179.5 billion in revenue for the fiscal third quarter, topping consensus estimates, and raised its fiscal-year guidance. The company separately announced it was transferring the listing of its common stock and nine bonds to the Nasdaq from the New York Stock Exchange.

Google parent Alphabet dropped 1.2%. Shares hit a record closing high on Wednesday of $292.82 amid rave reviews for Google’s new Gemini AI model. Alphabet stock has surged 56% this year. It was briefly on track to overtake Microsoft to become the third-largest U.S. company by market value.

International Business Machines gained 0.7%. The storied tech giant said it planned to develop a network of quantum computers alongside Cisco Systems, and would demonstrate the ability to link systems over increasingly longer distances by the early 2030s. Cisco stock turned 3.8% lower after rising earlier in the session.

Palo Alto Networks fell 7.4%. The cybersecurity company’s earnings and revenue forecast met analysts’ expectations but failed to impress investors. Palo Alto Networks also said it intends to purchase Chronosphere, a cybersecurity company focused on observability tools, for $3.35 billion.

Cipher Mining fell 0.4%. The data center operator unveiled a $830 million expansion to its existing agreement with Fluidstack, an AI cloud platform. The deal is backed by Google.

PACS Group soared 55%. Third-quarter revenue at the nursing home operator came in at $1.34 billion, topping the $1.11 billion analysts were anticipating, while earnings missed forecasts. For the full year, PACS sees revenue in the range of $5.25 billion to $5.35 billion, sharply above the $4.87 billion analysts were expecting. The company also said it was compliant with Securities and Exchange Commission filing requirements after months of uncertainty.

Bath & Body Works slumped 25%. The maker of body lotion and scented candles posted worse-than-expected earnings and sales in its fiscal third quarter and lowered its fiscal-year guidance, citing “recent negative macro consumer sentiment weighing heavily on our consumers’ purchase intent.”

Oddity Tech gained 6.5%. The consumer tech company posted $147.9 million in revenue in its third quarter, above FactSet consensus estimates of $145.5 million, and adjusted earnings of 40 cents a share, topping calls for 36 cents. Oddity also boosted its net revenue and adjusted earnings guidance for the full year.

Regeneron Pharmaceuticals climbed 5%. The drugmaker said the Food and Drug Administration had approved Eylea HD for the treatment of patients with macular edema following retinal vein occlusion, a common cause of vision impairment in adults.

Jacobs Solutions pared earlier gains and turned 11% lower. Fourth-quarter adjusted earnings of $1.75 a share topped the $1.68 consensus among analysts polled by FactSet. Gross revenue rose 6.6% to $3.15 billion, in line with expectations.

Earnings were expected after the bell Thursday from apparel retailer Gap, software company Intuit, cloud software provider Veeva Systems, and trading platform Webull.

Write to Mackenzie Tatananni at mackenzie.tatananni@barrons.com and George Glover at george.glover@dowjones.com